M Doganay, B Aygen - International journal of infectious diseases, 2003 - Elsevier
Brucellosis exists worldwide. The disease mainly spreads by ingestion of unpasteurized dairy products. It is a systemic disease, and many systems can be involved. The clinical …
Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations | PLOS Medicine Skip to main content Advertisement PLOS Medicine …
Despite the introduction of newer, less toxic antimicrobial agents, the aminoglycosides continue to serve a useful role in the treatment of serious enterococcal, mycobacterial, and …
J Solera, E Lozano, E Martínez-Alfaro… - Clinical infectious …, 1999 - academic.oup.com
Abstract Thirty-five patients aged 14–74 years (average, 54 years) who had brucellar spondylitis were treated between January 1991 and December 1997. The time from onset of …
R Yousefi‐Nooraie, S Mortaz‐Hejri… - Cochrane Database …, 2012 - cochranelibrary.com
Background Brucellosis is the most common zoonotic infection in the world. Several antibiotics, separately or in combination, have been tried for treatment of human brucellosis …
As more original molecular protocols and subsequent modifications are described in the literature, it has become difficult for those not directly involved in the development of these …
SM Alavi, L Alavi - Caspian journal of internal medicine, 2013 - ncbi.nlm.nih.gov
Background: The treatment of human brucellosis is controversial. The purpose of this study was to search published clinical trial papers to provide a simple and effective treatment in …
Epididymoorchitis is a focal form of human brucellosis described in 2%–20% of patients with brucellosis. We assessed 59 cases of Brucella epididymoorchitis (BEO) between 1991 and …
M Maurin, D Raoult - Antimicrobial agents and chemotherapy, 2001 - Am Soc Microbiol
Soon after antibiotics were introduced into medical practice, authors pointed out that microorganisms capable of surviving within phagocytic cells may be protected from the …